Copyright
©The Author(s) 2021.
World J Gastrointest Pharmacol Ther. Jan 5, 2021; 12(1): 1-12
Published online Jan 5, 2021. doi: 10.4292/wjgpt.v12.i1.1
Published online Jan 5, 2021. doi: 10.4292/wjgpt.v12.i1.1
Table 1 Predictive formulas for calculating energy expenditure[8]
Ref. | Age range | Gender | Equation |
Harris and Benedict[21] | Non-specifed | Male | 66.437 + [5.0033 × H (cm)] + [13.7516 × W (kg)] – [6.755 × Y (yr)] |
Non-specifed | Female | 655.0955 + [1.8496 × H (cm)] + [9.5634 × W (kg)] – [4.6756 × Y (yr)] | |
Schofield[22] in kcal/day | 10-17 | Male | [0.074 × W (kg) + 2.754] × 239 |
Female | [0.056 × W (kg) + 2.898] × 239 | ||
18-29 | Male | [0.063 × W (kg) + 2.896] × 239 | |
Female | [0.062 × W (kg) + 2.036] × 239 | ||
30-59 | Male | [0.048 × W (kg) + 3.653] × 239 | |
Female | [0.034 × W (kg) + 3.538] × 239 | ||
From 60 yr | Male | [0.049 × W (kg) + 2.459] × 239 | |
Female | [0.038 × W (kg) + 2.755] × 239 | ||
WHO[23] in kcal/day | 10-17 | Male | 17.5 × W + 651 |
Female | 12.2 × W + 746 | ||
18-29 | Male | 15.3 × W + 679 | |
Female | 14.7 × W + 496 | ||
30-59 | Male | 11.6 × W + 879 | |
Female | 8.7 × W + 829 | ||
From 60 yr | Male | 13.5 × W + 487 | |
Female | 10.5 × W + 596 | ||
Mifflin et al[24] in kcal/day | 19-78 | Male | 10 × W (kg) + 6.25 × H (cm) – 5 × Y (yr) + 5 |
19-78 | Female | 10 × W (kg) + 6.25 × H (cm) – 5 × Y(yr) – 161 | |
FAO/WHO[17] | 10-17 | Male | (16.6 × W) + [77 × H(m)] + 572 |
Female | (7.4 × W) + [482 × H (m)] + 217 | ||
18-30 | Male | (15.4 × W) – [27 × H (m)] + 717 | |
Female | (13.3 × W) + [334 × H (m)] + 35 | ||
31-60 | Male | (11.3 × W) + [16 × H (m)] + 901 | |
Female | (8.7 × W) – [25 × H (m)] + 865 | ||
From 60 yr | Male | (8.8 × W) + [1128 × H (m)] – 1071 | |
Female | (9.2 × W) + [637 × H (m)] – 302 | ||
IOM[25] | Non-specifed | Male | 293 – (3.8 × age) + (401.5 × height) + (8.6 × weight) |
Non-specifed | Female | 247 – (2.67 × age) + (456.4 × height) + (10.12 × weight) | |
Cunningham[26] | Non-specifed | Male, Female | 500 kcal + (lean mass in kg × 22) |
McArdle et al[27] | Non-specifed | Male, Female | (lean mass in kg × 21.6) + 370 |
Table 2 Sample characterization - cirrhotics with and without hepatocellular carcinoma (n = 118)
Variables | HCC (n = 33) | Without HCC (n = 85) | 1P value |
mean ± SD | mean ± SD | ||
Age (yr) | 62.8 ± 8.1 | 56.7 ± 9.4 | 0.001 |
Male gender | 26 (78.8%) | 37 (43.5%) | 0.0012 |
Weight (kg) | 73.9 ± 12.9 | 78.2 ± 17.2 | 0.206 |
Height (m) | 1.65 ± 0.09 | 1.65 ± 0.09 | 0.810 |
BMI (kg/m2) | 27.0 ± 4.0 | 28.7 ± 5.7 | 0.115 |
Lean mass (kg) | 51.3 ± 10.6 | 53.4 ± 12.3 | 0.396 |
Child Pugh | 0.2242 | ||
A | 13 (39.4%) | 32 (37.6%) | |
B | 17 (51.5%) | 34 (40.0%) | |
C | 3 (9.1%) | 19 (22.4%) | |
BCLC | - | ||
0 | 4 (12.1%) | - | |
A | 12 (36.4%) | - | |
B | 10 (30.3%) | - | |
C | 4 (12.1%) | - | |
D | 3 (9.1%) | - |
Table 3 Energy expenditure at rest by indirect calorimetry in cirrhotics with and without hepatocellular carcinoma (n = 118)
Variables | HCC (n = 33) | Without HCC (n = 85) | 1P value | ||
mean ± SD | IC 95% | mean ± SD | IC 95% | ||
Calorimetry | 1643 ± 364 | 1514–1772 | 1526 ± 277 | 1466–1586 | 0.064 |
Table 4 Resting energy expenditure by electrical bioimpedance in cirrhotics with and without hepatocellular carcinoma, compared with indirect calorimetry (n = 118)
Variables | HCC (n = 33) | Without HCC (n = 85) | |||
mean ± SD | IC 95% | mean ± SD | IC 95% | 1P value | |
BIA | 1529 ± 501 | 1352–1707 | 1660 ± 385 | 1577–1743 | 0.133 |
Calorimetry | 1643 ± 364 | 1606–1907 | 1526 ± 277 | 1356-1623 | 0.064 |
P value | 0.136 | 0.001 |
Table 5 Resting energy expenditure calculated using predictive formulas in cirrhotics with and without hepatocellular carcinoma (n = 118)
Variables | HCC (n = 33) | Without HCC (n = 85) | 1P value | ||
mean ± SD | IC 95% | mean ± SD | IC 95% | ||
Harris and Benedict[20] formula | 1466 ± 224 | 1387–1546 | 2138 ± 499 | 2030-2246 | < 0.001 |
Schofield[22] formula | 1489 ± 203 | 1417–1561 | 1539 ± 218 | 1491-1586 | 0.265 |
WHO[23] formula | 1518 ± 208 | 1444–1592 | 1536 ± 282 | 1475-1597 | 0.744 |
Mifflin et al[24] | 1433 ± 196 | 1363–1503 | 1439 ± 212 | 1393-1485 | 0.883 |
FAO/WHO formula[17] | 1522 ± 208 | 1449–1596 | 1566 ± 223 | 1518-1614 | 0.333 |
IOM[25] formula | 1402 ± 168 | 1342–1462 | 1544 ± 242 | 1491-1596 | 0.001 |
Cunningham[26] formula | 1629 ± 233 | 1546–1712 | 1674 ± 271 | 1616-1733 | 0.396 |
McArdle et al[27] formula, 1996 | 1478 ± 229 | 1397–1559 | 1523 ± 266 | 1466-1581 | 0.396 |
Table 6 Differences between resting energy expenditure calculated using predictive formulas in cirrhotic patients with hepatocellular carcinoma, compared with indirect calorimetry (n = 118)
Mean difference | IC 95% | 1P value | |
Calorimetry X Harris Benedict formula[21] | 177 | 59.8 a 293 | 0.004 |
Calorimetry X Schofield formula[22] | 154 | 36.9 a 270 | 0.011 |
Calorimetry X WHO formula[23] | 125 | 9.1 a 240 | 0.035 |
Calorimetry X Mifflin et al[24] formula | 210 | 98.5 a 321 | 0.001 |
Calorimetry X FAO/WHO formula[17] | 120 | -2.3 a 243 | 0.054 |
Calorimetry x IOM formula[25] | 241 | 116 a 366 | < 0.001 |
Calorimetry x Cunningham formula[26] | 14 | -101 a 129 | 0.806 |
Calorimetry x McArdle et al[27] formula | 165 | 49.5 a 279 | 0.006 |
Table 7 Differences between resting energy expenditure calculated using predictive formulas in cirrhotics without hepatocellular carcinoma, compared with indirect calorimetry (n = 118)
Mean difference | IC 95% | 1P value | |
Calorimetry X Harris Benedict formula[21] | -611 | -691 a -531 | < 0.001 |
Calorimetry X Schofield formula[22] | -12.3 | -67.2 a 42.6 | 0.658 |
Calorimetry X WHO formula[23] | -9.5 | -73.1 a 54.2 | 0.768 |
Calorimetry X Mifflin-St Jeo formula[24] | 87.2 | 49.5 a 125 | < 0.001 |
Calorimetry X FAO/WHO formula[17] | -39.8 | -93.2 a 13.6 | 0.142 |
Calorimetry x IOM formula[25] | -17.5 | -41.5 a 6.6 | 0.153 |
Calorimetry x Cunningham formula[26] | -148 | -172 a -123 | < 0.001 |
Calorimetry x McArdle et al[27] formula | 3.2 | -20.9 a 27.3 | 0.792 |
- Citation: Henz AC, Marroni CA, Silva DMD, Teixeira JM, Silveira TT, Ferreira S, Silveira AT, Schmidt NP, Stein JT, Rayn RG, Fernandes SA. Resting energy expenditure in cirrhotic patients with and without hepatocellular carcinoma. World J Gastrointest Pharmacol Ther 2021; 12(1): 1-12
- URL: https://www.wjgnet.com/2150-5349/full/v12/i1/1.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v12.i1.1